| Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 T Zhou, I Georgiev, X Wu, ZY Yang, K Dai, A Finzi, Y Do Kwon, JF Scheid, ... Science 329 (5993), 811-817, 2010 | 1281 | 2010 |
| mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin, H Glantz, ... Science 372 (6549), 1413-1418, 2021 | 485 | 2021 |
| Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops YD Kwon, A Finzi, X Wu, C Dogo-Isonagie, LK Lee, LR Moore, ... Proceedings of the National Academy of Sciences 109 (15), 5663-5668, 2012 | 265 | 2012 |
| Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity M Veillette, A Désormeaux, H Medjahed, NE Gharsallah, M Coutu, ... Journal of virology 88 (5), 2633-2644, 2014 | 261 | 2014 |
| HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4AVPRBP E3 Ubiquitin Ligase JP Belzile, G Duisit, N Rougeau, J Mercier, A Finzi, ÉA Cohen PLoS pathogens 3 (7), e85, 2007 | 230 | 2007 |
| Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions A Finzi, SH Xiang, B Pacheco, L Wang, J Haight, A Kassa, B Danek, ... Molecular cell 37 (5), 656-667, 2010 | 228 | 2010 |
| Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike J Prévost, R Gasser, G Beaudoin-Bussières, J Richard, R Duerr, ... Cell Reports Medicine 1 (7), 100126, 2020 | 196 | 2020 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 195 | 2021 |
| A B-box 2 surface patch important for TRIM5α self-association, capsid binding avidity, and retrovirus restriction F Diaz-Griffero, X Qin, F Hayashi, T Kigawa, A Finzi, Z Sarnak, M Lienlaf, ... Journal of virology 83 (20), 10737-10751, 2009 | 194 | 2009 |
| Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals AE Baxter, J Niessl, R Fromentin, J Richard, F Porichis, R Charlebois, ... Cell host & microbe 20 (3), 368-380, 2016 | 182 | 2016 |
| The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals M Veillette, M Coutu, J Richard, LA Batraville, O Dagher, N Bernard, ... Journal of virology 89 (1), 545-551, 2015 | 176 | 2015 |
| Macrophage infection via selective capture of HIV-1-infected CD4+ T cells AE Baxter, RA Russell, CJA Duncan, MD Moore, CB Willberg, JL Pablos, ... Cell host & microbe 16 (6), 711-721, 2014 | 173 | 2014 |
| Resistance of transmitted founder HIV-1 to IFITM-mediated restriction TL Foster, H Wilson, SS Iyer, K Coss, K Doores, S Smith, P Kellam, A Finzi, ... Cell host & microbe 20 (4), 429-442, 2016 | 166 | 2016 |
| Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, ... MBio 11 (5), e02590-20, 2020 | 159 | 2020 |
| Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET M Lu, X Ma, LR Castillo-Menendez, J Gorman, N Alsahafi, U Ermel, ... Nature 568 (7752), 415-419, 2019 | 145 | 2019 |
| Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset SP Anand, J Prévost, M Nayrac, G Beaudoin-Bussières, M Benlarbi, ... Cell Reports Medicine 2 (6), 100290, 2021 | 144 | 2021 |
| Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer Y Mao, L Wang, C Gu, A Herschhorn, A Désormeaux, A Finzi, SH Xiang, ... Proceedings of the National Academy of Sciences 110 (30), 12438-12443, 2013 | 141 | 2013 |
| Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane A Finzi, A Orthwein, J Mercier, ÉA Cohen Journal of virology 81 (14), 7476-7490, 2007 | 141 | 2007 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 140 | 2021 |
| Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers MG Pauthner, JP Nkolola, C Havenar-Daughton, B Murrell, SM Reiss, ... Immunity 50 (1), 241-252. e6, 2019 | 127 | 2019 |
